Efficacy of a Peat and Salsobromoiodic Water Mask in the Treatment of Seborrheic Dermatitis of the Face
Key Findings
- Double-blind, prospective, placebo-controlled RCT: peat plus salsobromoiodic mineral water mask vs. vehicle-cream placebo, once daily for 2 weeks, in 82 patients with mild-to-moderate facial seborrheic dermatitis
- 78 of 82 patients completed the course; no significant baseline difference between groups
- Treatment group showed a statistically significant reduction in severity score versus placebo starting at day 7 (p < 0.05)
- By day 14 and at 1-month follow-up: significantly greater reduction in severity score, decreased sebum, and increased skin hydration versus placebo (p < 0.05 for all)
- No adverse effects reported in either group
A double-blind, placebo-controlled RCT testing a peat and salsobromoiodic mineral water mask against a vehicle-cream placebo in 82 patients with mild-to-moderate facial seborrheic dermatitis. The treatment group showed a statistically significant reduction in severity from day 7 onward, with sustained improvements in sebum control and skin hydration through a one-month follow-up and no adverse effects reported. This is currently the primary direct clinical evidence for peat face masks in seborrheic dermatitis. Sourced from an abstract listing rather than the full text, which sits behind a subscription paywall with no accessible PDF.
Where this source is used on this site
Each page below cites this paper as evidence for a specific claim. The note shows what the page draws from it.
Double-blind RCT, 82 patients (78 completed): peat + salsobromoiodic water mask vs. placebo, significant reduction in severity score from day 7, improved sebometry/hydration through 1-month follow-up (p<0.05)
Double-blind RCT, 82 patients (78 completed): significant reduction in severity score from day 7, improved sebometry/hydration through 1-month follow-up (p<0.05), no adverse effects